Ballard Power Systems, Inc. is a global leader in PEM (proton exchange membrane) fuel cell technology. We provide clean energy fuel cell products enabling optimized power systems for a range of applications. Ballard offers smarter solutions for a clean energy future.
We are actively putting fuel cells to work in high-value commercial uses every day. In fact, Ballard has designed and shipped close to 150 MW of hydrogen fuel cell technology to date.
Current Business Focus
|Backup Power - Fuel cells provide a highly reliable and cost-competitive power source for backup power in wireless telecom networks worldwide.|
Distributed Generation – Fuel cells can take advantage of low-cost hydrogen streams from chemical and bio-gas production to generate power locally for onsite use or sale back to the grid.
|Engineering Services - A high-value way for companies to accelerate their fuel cell development efforts. Our fuel cell science, engineering and manufacturing skill sets are unsurpassed in the marketplace.|
|Material Handling - Fuel cell-powered material handling equipment improves productivity in high-throughput warehouses and distribution centers, creating a compelling return on investment.|
Bus - Fuel cell buses are clean vehicles, emitting no greenhouse gas or particulates matters and operate to the highest standards from the perspective of drivers, passengers and transit agencies.
Ballard Power Systems, Inc. was founded in 1979, under the name "Ballard Research Inc.", to conduct research and development on high-energy lithium batteries. In the course of investigating environmentally clean energy systems with commercial potential, the Company began developing fuel cells in 1983. Over time Ballard entered into a number of strategic alliances related to fuel cell R&D, including an alliance with Daimler AG and Ford Motor Company.
The company undertook a major corporate transformation from 2007 to 2009. Strategic focus shifted from long-term, high cost automotive fuel cell R&D technology development to clean energy fuel cell products for near-term commercial markets.